| PERIOD ENDING | 31-Dec-08 | 31-Dec-03 | 31-Dec-02 | | Total Revenue | 210,071 | 58,818 | 24,515 | | Cost of Revenue | 91,969 | 43,769 | 18,492 | | | Gross Profit | 118,102 | 15,049 | 6,023 | | | Operating Expenses | | Research Development | 59,809 | 16,938 | 15,549 | | Selling General and Administrative | 54,370 | 11,673 | 11,268 | | Non Recurring |
-
|
-
|
-
| | Others |
-
| (27) |
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,923 | (13,535) | (20,794) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 28,347 | 280 | 1,319 | | Earnings Before Interest And Taxes | 32,270 | (13,255) | (19,475) | | Interest Expense | 2,599 | 952 | 565 | | Income Before Tax | 29,671 | (14,207) | (20,040) | | Income Tax Expense | 10,971 |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,700 | (14,207) | (20,040) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 18,700 | (14,207) | (20,040) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $18,700 | ($14,207) | ($20,040) |
|
0.20% Nasdaq 
0.10%
Income Statement
